Objective: The aim of this study was to evaluate the diagnosis of sarcopenia by abdominal tomography, prevelance and prognosis in critical patient admitted to intensive care unit(ICU). Methods: It was planned as a retrospective observational study. Patients older than 40 years of age with abdominal tomography who needed to be in the ICU were included. Muscle mass was measured by abdominal tomography. All patients were divided into two groups as sarcopenic and non-sarcopenic according to the measurement results. We compared the prognosis and clinical features of patients with and without sarcopenia. Results: Fifty five(59%) of all patients were found as sarcopenic and 70.8% over 70 years of age. The length of stay in ICU and in hospital were 27.8 ± 29.7 and 33.0 ± 31.2 days in sarcopenic patients, 15.1±17 and 23.8±21.3 days in nonsarcopenic patients respectively(p <0.05). Thirty day mortality was found 49.1% in patients sarcopenic(<0.05). SMI was found lower over aged 70 years(p <0.05). Conclusions: Sarcopenia was associated with the increasing of 30 day mortality, a prolongation in the lenght of stay in ICU and hospital. Therefore, we believe that awareness about sarcopenia will be important in order to shorten the mortality and lenght of stay in ICU.

Objectives: During the pandemic, anxiety, stress, and depression may occur increasingly in the whole society. To evaluate the possible cause, incidence and levels of anxiety and depression in the relatives of the patients in the ICU in accordance with the patients’ SARS-CoV-2 PCR result. Materials and Method: The study was prospectively conducted on relatives of patients admitted to tertiary ICU during COVID-19 pandemic. Sociodemographic characteristics of the patients and their relatives were recorded. “The Turkish version of the Hospital Anxiety and Depression Scale” questionnaire was applied twice to the relatives of 120 patients to determine the symptoms of anxiety and depression in accordance with the PCR results of the patients (PCR positive n=60, PCR negative n=60). Results: The ratios above cut-off values for anxiety and depression among relatives of the patients were 45,8% and 67,5% for the first test and 46,7% and 62,5% for the second test respectively. The anxiety and depression in the relatives of PCR positive patients was more frequent than the PCR negative (p< 0,001 for HADS-A and p=0,034 for HADS-D). The prevalence of anxiety and depression was significantly higher in female participants (p=0,046 for HADS-A and p=0,009 for HADS-A). There was no significant correlation between HADS and age of the patient or education of the participants. The fact that the patients were hospitalized in the ICU during the pandemic was an independent risk factor for anxiety (AUC = 0.746) while restriction of patient visiting in the ICU was found to be an independent risk factor for depression (AUC= 0.703). Conclusion: While patient with positive PCR and participant with female gender is responsible for both anxiety and depression, hospitalization in the ICU due to COVID-19 is an independent risk factor for anxiety and restriction of patient visiting in the ICU is an independent risk factor for depression.